(Q37749805)

22 August 2017

1 reference

title

Re-engineering clostridial neurotoxins for the treatment of chronic pain: current status and future prospects (English)

1 reference

22 August 2017

0 references

Andy Pickett

1

1 reference

PubMed ID

20462283

22 August 2017

language of work or name

1 reference

1 June 2010

1 reference

22 August 2017

1 reference

22 August 2017

24

1 reference

22 August 2017

173-182

1 reference

22 August 2017

3

1 reference

https://scigraph.springernature.com/pub.10.2165/11534510-000000000-00000

22 August 2017

0 references

cites work

Double-blind, placebo-controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis

1 reference

https://api.crossref.org/works/10.2165%2F11534510-000000000-00000

Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystonia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11534510-000000000-00000

Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11534510-000000000-00000

Botulinum toxin A and chronic low back pain: a randomized, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11534510-000000000-00000

P2X receptors in sensory neurones

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11534510-000000000-00000

A randomized, double-blind, placebo controlled study on analgesic effects of botulinum toxin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11534510-000000000-00000

10.2165/11534510-000000000-00000

21 January 2018

Identifiers

DOI

1 reference

PubMed ID

20462283

Dimensions Publication ID

22 August 2017

0 references

1 reference

PubMed ID

20462283